Provided by Tiger Fintech (Singapore) Pte. Ltd.

Universe Pharmaceuticals Inc.

0.1030
-0.0178-14.74%
Post-market: 0.1024-0.0006-0.60%19:59 EDT
Volume:2.59M
Turnover:257.89K
Market Cap:1.57M
PE:0.00
High:0.1101
Open:0.1050
Low:0.0911
Close:0.1208
Loading ...
Jun 06, 2024

Correspondence

Form CORRESP - Correspondence
May 15, 2024

Correspondence

Form CORRESP - Correspondence
May 14, 2024

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Apr 24, 2024

Public Prospectus

Form F-1 - Registration statement for certain foreign private issuers
Jan 30, 2024

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 10, 2023

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 11, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 31, 2022

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 17, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 17, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 10, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 10, 2021

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Mar 01, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Mar 01, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Feb 24, 2021

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Dec 10, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses